NAD Nasal Spray in Indianapolis: What the Research Shows

NAD nasal spray is an intranasal preparation of nicotinamide adenine dinucleotide — a coenzyme central to mitochondrial energy production and DNA repair. For people in Indianapolis researching it, the spray is positioned as a non-injection delivery route for NAD+ support. A licensed clinician decides whether it fits your health profile, goals, and current medications.

If you live in Indianapolis and have been seeing NAD nasal spray mentioned in recovery clinics, longevity podcasts, or by friends training for the Mini-Marathon, you probably want a sober explanation rather than another marketing page. This article walks through what NAD+ actually does in cells, what peer-reviewed research has and hasn't shown about supplementation, and what a clinical conversation should cover.

What NAD+ does inside your cells

Nicotinamide adenine dinucleotide is a coenzyme found in every cell of the body. It exists in two interconverting forms — NAD+ (oxidized) and NADH (reduced) — and shuttles electrons through the reactions that turn food into ATP, the molecule your body burns for energy. Beyond bioenergetics, NAD+ is a substrate for sirtuins (proteins involved in metabolic regulation), PARPs (DNA-damage repair enzymes), and CD38 (an immune-cell ectoenzyme). Tissue concentrations of NAD+ decline with age, with chronic inflammation, and after sustained metabolic stress, and that decline has been a major focus of aging research over the last decade (Verdin, Science 2015).

That biology is why the clinician-supervised NAD+ nasal program at Body Good Men is grouped under "recovery" rather than as a stimulant or a hormone. The hypothesis is that supporting NAD+ availability supports the cellular machinery that's been downregulated — not that it produces a specific symptomatic outcome on a predictable timeline.

Why intranasal delivery — the bioavailability question

Oral NAD+ is degraded in the gut, and oral NAD+ precursors (nicotinamide riboside, or NR; nicotinamide mononucleotide, or NMN) are converted before they reach systemic circulation. Injection bypasses the gut but requires a needle and clinical setting. Intranasal delivery sits between the two: a mist is sprayed into the nasal cavity, where the highly vascular mucosa offers a rapid absorption surface and, for some molecules, a route of access to the central nervous system through the olfactory and trigeminal nerve pathways (Erdő et al., Brain Res Bull 2018).

Whether NAD+ specifically reaches the brain in meaningful concentrations through this route is still an open research question — most of the published intranasal CNS-delivery work has been in rodents and with smaller molecules. Patients in Indianapolis researching the spray should understand that "alternative to injection" is the strongest framing supported by current evidence, not "equivalent to injection" and not "delivers NAD+ to the brain." Pharmacokinetics in humans, dose-response, and tissue distribution for intranasal NAD+ are not yet established at the level of evidence we have for the oral precursors.

What published research actually shows

The NAD+ precursor literature is the most useful starting point for a realistic expectation set. In a randomized placebo-controlled trial of nicotinamide riboside, healthy middle-aged and older adults who took 1 g per day for six weeks showed a sustained ~60% increase in blood NAD+ metabolites compared with placebo, with no serious adverse events reported (Martens et al., Nature Communications 2018). An earlier crossover study established that single oral doses of nicotinamide riboside produced dose-dependent increases in whole-blood NAD+ metabolome markers (Trammell et al., Nature Communications 2016).

A broader review in Cell Metabolism concluded that NAD+ precursors raise tissue NAD+ in human and animal studies but cautioned that translating biomarker shifts into specific clinical endpoints — fatigue, cognition, athletic recovery — still requires larger, longer trials (Rajman et al., Cell Metabolism 2018). The pattern across the literature is consistent: NAD+ levels can be moved with supplementation, but the clinical questions most patients care about ("Will I feel better? Recover faster? Sleep deeper?") have not yet been answered with the rigor that exists for, say, GLP-1 medications or PDE5 inhibitors.

For a comparable peptide-class education, see the related NAD+ injectable program overview, which covers the same coenzyme delivered by a different route.

NAD+ in Indianapolis: the local context

Indianapolis is unusually represented in NAD+ conversations for a few reasons. It's a major training city — the OneAmerica 500 Festival Mini-Marathon is the largest half marathon in the United States, drawing roughly 25,000 runners through the Speedway oval each May — and recovery is a real conversation in that community. It's also a pharmaceutical research hub, with Eli Lilly's headquarters and a dense network of clinical-trial sites. That combination means Indianapolis residents tend to encounter NAD+ in two very different contexts: as wellness positioning at recovery studios, and as a research-grade molecule discussed inside life-sciences workplaces.

Both contexts can be valid, and they pull in opposite directions. Marketing-led NAD+ messaging tends to overpromise. Research-led messaging tends to underclaim. The honest middle is: NAD+ biology is real, the precursor science is real, the data on intranasal NAD+ in humans is thin, and individual response varies. Indianapolis winters are also long and dry — anyone considering any nasal preparation should mention chronic sinusitis, allergies, or septum issues to their clinician, because intranasal delivery isn't appropriate for everyone.

How a clinician evaluates a candidate

A clinician offering a NAD+ nasal spray program through a telehealth model is doing more than dispensing a product. The intake review typically covers current medications and supplements, kidney and liver function (NAD+ metabolism touches both), nasal and sinus history, neurologic symptoms, history of cancer (because NAD+ pathways interact with PARP-driven DNA repair), pregnancy or planning, and what the patient is trying to achieve. The clinician then determines whether the spray is appropriate at all, whether a different NAD+ delivery route fits better, or whether a different intervention entirely — sleep evaluation, iron studies, thyroid panel, cardiopulmonary workup — should come first. Fatigue and "low energy" are common chief complaints with many causes, and skipping the workup in favor of a recovery product is rarely the right call.

Questions worth bringing to your provider

If you're reviewing the NAD+ nasal spray clinical pathway at Body Good Men and you want a productive intake, write down the following before the visit:

• What outcome am I actually hoping for, and what would make me say this worked?
• What baseline labs or evaluations should I have before starting?
• Are there any medications or conditions in my history that make this inappropriate?
• How will we know whether to continue, adjust, or stop after the first cycle?
• What does the published evidence support for this delivery route specifically, and what is extrapolated?

A good clinician will welcome these questions. If a provider can't or won't answer them, that's information too.

Frequently asked questions

Is NAD nasal spray safe?

Across published trials of oral NAD+ precursors at standard doses, safety has been favorable, with mostly mild and transient side effects (Martens et al., Nat Commun 2018; Conze et al., Sci Rep 2019). Intranasal NAD+ specifically has less published human data, so safety is best assessed individually with a clinician who reviews your medications, sinus history, and conditions like cancer history or pregnancy.

How long does NAD nasal spray take to work?

There is no published, peer-reviewed timeline for intranasal NAD+ in humans. Patients describe a wide range of experiences, and what counts as "working" depends on the goal — perceived energy, sleep, recovery, or focus. Setting a defined check-in window with your clinician, with specific symptoms or measures to track, is more useful than chasing a generic timeframe.

Is NAD nasal spray legal in Indianapolis?

NAD+ is a naturally occurring coenzyme. Compounded NAD+ preparations are dispensed by licensed pharmacies through a clinician's prescription, and Indiana follows federal compounding rules administered by the FDA and the Indiana Board of Pharmacy. Whether a specific preparation is appropriate for you is a clinical question for a licensed provider, not a legal one for the patient.

What's the difference between NAD nasal spray and NAD injections?

Both deliver NAD+ outside the gut, but the routes differ. Subcutaneous or intramuscular injection delivers a known dose into systemic circulation. Intranasal delivery uses the nasal mucosa as the absorption surface; bioavailability is lower and less predictable in published research. Your clinician chooses between routes based on your goals, anatomy, and tolerance — see also the intramuscular NAD+ option.

Do you need a prescription for NAD nasal spray?

Yes. Compounded NAD+ nasal preparations require a prescription from a licensed clinician who has evaluated you. The Body Good Men intake routes you through that evaluation; the clinician — not the website — decides whether to prescribe.

Talk to a clinician

If you're considering NAD+ supplementation and want to know whether it's appropriate for you, talk to a licensed clinician. The NAD+ nasal spray program at Body Good Men connects you with a US-licensed clinician who reviews your eligibility and, if appropriate, prescribes through our partner pharmacy.

---

Important Disclosure

men.joinbodygood.com is operated as an affiliate of Body Good Studio LLC and is a whitelabel certified partner of Leg Up Rx. men.joinbodygood.com does not provide medical services, prescribe medications, or maintain patient records. All clinical evaluations, prescription decisions, and medication fulfillment are handled by licensed medical and pharmacy partners through Leg Up Rx. This article is for general informational purposes only and is not medical advice. Talk to a licensed healthcare provider before starting any treatment. Eligibility for any medication is determined solely by a licensed clinician.

---